A Study to Assess Pregnancy Outcomes in Women Exposed to Diroximel Fumarate

Condition:   Multiple Sclerosis Interventions:   Drug: Diroximel Fumarate;   Biological: Alemtuzumab;   Drug: Fingolimod;   Drug: Glatiramer acetate;   Biological: Interferon beta;   Biological: Natalizumab;   Biological: Ocrelizumab;   Biological: Peginterferon beta-1a;   Drug: Siponimod Sponsor:   Biogen Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials